What is Parkinson's Phase 3 Study Creatine?

Category: Others


See also: Clinical Trial

NCT00449865 is a multicenter, double-blind, parallel group, placebo controlled study of creatine in subjects with treated Parkinson's Disease (PD) Long Term Study (LS-1). Other study IDs include: U01NS43128 NET-PD, CRC, NET-PD LS-1.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Parkinson's Phase 3 Study Creatine

Side effect Patients
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Last updated:
There are no evaluations for Parkinson's Phase 3 Study Creatine.